live
recombin
bacteria
repres
attract
antigen
deliveri
system
abl
induc
mucos
system
immun
respons
heterolog
antigen
first
live
recombin
bacteri
vector
develop
deriv
attenu
pathogen
microorgan
addit
difficulti
often
encount
construct
stabl
attenu
mutant
pathogen
organ
attenu
pathogen
may
retain
residu
virul
level
render
unsuit
vaccin
partial
immunocompet
individu
infant
elderli
immunocompromis
patient
altern
strategi
nonpathogen
foodgrad
lactic
acid
bacteria
lab
mayb
use
live
antigen
carrier
articl
review
lab
vaccin
construct
use
antigen
tetanu
toxin
fragment
c
bacteri
viral
parasit
infect
agent
protect
studi
perform
antigen
util
develop
lab
vaccin
briefli
describ
along
effici
system
protect
studi
moreov
key
factor
affect
perform
system
highlight
vaccin
repres
one
effect
public
health
strategi
combat
infecti
diseas
one
technolog
develop
vaccin
product
use
bacteria
live
vector
deliveri
recombin
vaccin
antigen
immun
system
vaccin
potenti
product
protect
antigen
vivo
inexpens
manufactur
moreov
possibl
simultan
express
multipl
antigen
bacteria
result
develop
multival
vaccin
requir
reduc
number
administr
infect
affect
initi
infecti
process
mucos
surfac
mucos
local
immun
respons
block
pathogen
portal
entri
live
bacteri
vaccin
induc
mucos
well
system
immun
respons
deliv
via
mucos
rout
oral
intranas
administr
mucos
needlefre
administr
vaccin
significantli
decreas
need
syring
inher
ad
cost
risk
diseas
transmiss
increas
complianc
consequ
coverag
vaccin
program
use
live
bacteri
vector
vaccin
deliveri
first
describ
earliest
live
bacteri
vector
deriv
pathogen
microorgan
shigella
salmonella
listeria
mycobacterium
case
stabl
attenu
mutant
longer
pathogen
remain
immunogen
must
first
select
construct
step
tediou
time
consum
mani
instanc
addit
attenu
pathogen
strain
retain
residu
virul
level
unlik
suitabl
vaccin
partial
immunocompet
individu
infant
elderli
immunocompromis
patient
problem
address
applic
safe
organ
lactic
acid
bacteria
lab
antigen
deliveri
vehicl
sinc
time
immemori
lab
use
ferment
preserv
food
product
particularli
dairi
product
ferment
meat
veget
consequ
long
record
safe
associ
human
human
foodstuff
addit
exhibit
adjuv
properti
weakli
immunogen
lab
therefor
repres
attract
altern
antigen
carrier
use
mainli
focus
construct
mucos
vaccin
minireview
describ
recent
advanc
develop
lab
vaccin
bacteria
virus
parasit
review
lab
vaccin
design
use
antigen
tetanu
toxin
fragment
c
ttfc
protect
studi
carri
result
obtain
ttfc
conclus
review
elsewher
describ
studi
devot
express
antigen
lab
andor
analysi
immunolog
respons
absenc
function
assay
balbc
mice
mainli
use
studi
explain
articl
evalu
immunolog
respons
protect
level
unless
otherwis
state
addit
control
group
mice
refer
mice
vaccin
control
bacteria
parent
bacteri
host
carri
express
vector
without
antigen
encod
gene
method
use
immun
control
group
mice
ident
test
group
mice
inocul
lab
vaccin
deviat
condit
indic
text
streptococc
infect
lab
use
carrier
antigen
sever
bacteri
pathogen
tabl
protein
streptococcu
pyogen
group
streptococci
ga
virul
factor
facilit
colon
mucos
tissu
organ
enabl
evad
host
immun
surveil
crepeat
region
crr
protein
contain
sequenc
conserv
among
mani
serotyp
ga
mice
vaccin
nasal
nasal
subcutan
lactococc
vaccin
express
crr
protein
pyogen
cell
surfac
challeng
nasal
pyogen
evalu
protect
level
pharyng
infect
twentyf
percent
mice
vaccin
nasal
recombin
l
lacti
infect
pyogen
wherea
mice
control
group
infect
furthermor
mice
immun
combin
regimen
acquir
infect
wherea
mice
control
group
infect
howev
mice
vaccin
subcutan
recombin
lactococci
protect
pharyng
infect
analysi
correl
antibodi
respons
protect
suggest
crrspecif
salivari
iga
antibodi
induc
mice
follow
nasal
immun
necessari
suffici
prevent
pharyng
infect
recent
demonstr
streptococcu
agalactia
group
b
streptococci
gb
produc
three
type
pili
encod
three
genom
island
express
pilin
island
lactococcu
lacti
result
assembl
pilu
cell
surfac
immun
femal
mice
subcutan
intranas
recombin
l
lacti
led
protect
offspr
lethal
intraperiton
challeng
gb
harbor
pilu
howev
level
protect
follow
mucos
immun
lower
observ
system
immun
mice
control
group
immun
parent
lactococci
surviv
challeng
gb
harbor
pilu
subcutan
immun
femal
mice
recombin
lactococci
express
hybrid
pilu
consist
gb
pilu
gb
pilu
compon
confer
protect
pup
intraperiton
challeng
gb
strain
carri
either
pilu
pilu
respect
serotypeindepend
pneumococc
surfac
protein
repres
promis
candid
design
vaccin
streptococcu
pneumonia
one
candid
pneumococc
surfac
protein
pspa
cholin
bind
protein
essenti
full
virul
pneumococci
nasal
immun
mice
lactobacillu
casei
express
ntermin
region
pspa
intracellularli
result
signific
induct
antipspa
igg
sera
howev
antipspa
iga
detect
pool
saliva
nasal
wash
elicit
antipspa
igg
abl
bind
nativ
pspa
cell
surfac
pneumococc
strain
induc
complement
deposit
surfac
pneumococci
differ
extent
depend
pneumococc
speci
surviv
observ
control
group
mice
system
challeng
virul
pneumococc
strain
howev
mice
immun
l
casei
produc
pspa
surviv
pneumococc
challeng
intranas
vaccin
cbaca
mice
l
lacti
express
ntermin
region
pspa
intracellularli
afford
protect
respiratori
challeng
pneumonia
better
elicit
purifi
antigen
administ
intranas
inject
alum
find
attribut
shift
toward
respons
surviv
mice
control
group
respiratori
challeng
suggest
l
lacti
alon
may
contribut
nonspecif
host
immun
intraperiton
challeng
pneumonia
lactococc
nasal
vaccin
afford
resist
infect
similar
obtain
inject
purifi
antigen
vaccin
produc
equival
mean
surviv
time
h
wherea
surviv
time
mice
control
group
h
surviv
time
control
mice
respiratori
pnemococc
challeng
h
wherea
mice
immun
nasal
lactococc
vaccin
h
inactiv
lactococc
vaccin
still
afford
protect
respiratori
challeng
pneumonia
surviv
time
mice
vaccin
mitomycin
cinactiv
lactococc
vaccin
follow
respiratori
pnemococc
challeng
h
reduc
efficaci
inactiv
vaccin
respiratori
challeng
mayb
explain
shift
toward
respons
anoth
studi
pneumococc
surfac
antigen
psaa
conserv
membraneanchor
virul
factor
express
differ
strain
lab
cell
wall
associ
form
lactobacillu
plantarum
lactobacillu
helveticu
found
effect
induc
mucos
system
antipsaa
immun
respons
l
casei
follow
intranas
vaccin
mice
three
lactobacillu
strain
express
almost
amount
psaa
also
recov
mice
nasal
mucosa
period
day
observ
differ
among
respect
antibodi
respons
may
reflect
differ
intrins
adjuv
properti
psaa
express
l
lacti
ngcoloni
form
unit
cfu
psaa
amount
produc
lactobacillu
strain
recombin
l
lacti
remain
nasal
mucosa
day
inocul
therefor
inabl
l
lacti
express
psaa
significantli
induc
serum
igg
secret
iga
mice
explain
low
level
antigen
product
bacterium
compar
lactobacillu
strain
also
shorter
persist
nasal
mucosa
intranas
inocul
mice
l
lacti
express
psaa
exert
effect
pneumonia
recoveri
nasal
mucosa
upon
colon
challeng
comparison
inocul
salin
control
bacterium
hand
recombin
lactobacillu
strain
show
signific
reduct
pneumonia
colon
compar
salin
group
cfu
howev
l
helveticu
express
psaa
show
signific
reduct
pneumonia
colon
relat
control
l
helveticu
cfu
among
lab
l
lacti
lactobacillu
strain
mostli
use
construct
lab
vaccin
select
lab
strain
use
antigen
carrier
depend
persist
host
capac
express
foreign
antigen
intrins
adjuvant
l
lacti
colon
intern
caviti
man
anim
therefor
use
lactobacilli
abl
colon
caviti
gastrointestin
tract
git
transient
seem
advantag
l
lacti
develop
lab
vaccin
longer
persist
lactobacilli
host
bodi
may
enhanc
immunolog
respons
hand
progress
genet
lactobacilli
recent
lactococci
furthermor
avail
commerci
power
gene
express
system
l
lacti
nisin
induc
gene
express
system
urg
mani
research
establish
lab
vaccin
base
lactococci
report
sever
lab
strain
particularli
strain
genera
lactobacillu
abl
act
adjuv
aspect
consid
select
vaccin
strain
natur
way
potenti
immun
reaction
heterolog
antigen
produc
recombin
lab
might
specul
high
level
antigen
express
necessari
use
immunostimulatori
lab
strain
howev
studi
yet
report
comparison
adjuvant
l
lacti
differ
lactobacilli
l
casei
l
plantarum
among
lactobacillu
strain
colon
git
human
mice
show
immunostimulatori
properti
pneumococc
surfac
protein
identifi
pneumococc
protect
protein
pppa
antigen
conserv
among
differ
serotyp
strain
pneumonia
nasal
immun
swiss
albino
mice
recombin
lactococci
express
pppa
cell
surfac
l
lacti
pppa
induc
strong
mucos
system
immun
respons
significantli
higher
young
mice
adult
mice
vaccin
l
lacti
pppa
increas
resist
system
respiratori
infect
differ
pneumococc
serotyp
adult
mice
immun
l
lacti
pppa
show
surviv
percentag
day
intraperiton
challeng
serotyp
strain
pneumonia
howev
mice
immun
l
lacti
without
induct
pppa
express
l
lacti
pppa
die
day
postchalleng
vaccin
young
mice
l
lacti
pppa
enabl
anim
surviv
day
young
mice
vaccin
l
lacti
pppa
die
day
postchalleng
furthermor
lung
bacteri
cell
count
neg
respiratori
challeng
either
serotyp
pneumococc
strain
adult
young
mice
vaccin
l
lacti
pppa
contrast
control
anim
pneumonia
serotyp
use
challeng
detect
lung
cultur
almost
helicobact
pylori
strain
produc
special
ureas
decompos
urea
form
ammonia
harm
gastric
mucosa
ureas
compos
four
subunit
among
subunit
b
ureb
show
strongest
antigen
among
h
pylori
protein
ureb
antigen
express
extracellularli
l
lacti
oral
inocul
mice
recombin
lactococci
elicit
urebspecif
serum
igg
respons
furthermor
specif
antiureb
iga
respons
could
also
detect
fece
immun
mice
follow
intragastr
challeng
h
pylori
h
pylori
count
stomach
mice
vaccin
ureb
produc
lactococci
cfug
stomach
wherea
control
mice
cfug
stomach
anoth
studi
potenti
wild
type
l
plantarum
mutant
l
plantarum
affect
cellwal
composit
result
inactiv
alanin
racemas
gene
evalu
deliv
ureb
antigen
git
mous
model
helicobact
feli
infect
mice
vaccin
intragastr
recombin
lactobacillu
strain
also
mixtur
recombin
ureb
cholera
toxin
rurebct
oral
challeng
h
feli
h
feli
load
stomach
mice
immun
ureb
produc
l
plantarum
cfug
gastric
tissu
slightli
lower
control
mice
cfug
gastric
tissu
h
feli
load
mice
immun
ureb
produc
mutant
l
plantarum
cfug
gastric
tissu
result
indic
alanin
racemas
mutant
l
plantarum
promot
pronounc
reduct
h
feli
load
stomach
immun
mice
wild
type
counterpart
h
feli
load
mice
immun
rurebct
cfu
g
gastric
tissu
therefor
highest
degre
protect
h
feli
achiev
rurebct
enterotoxin
enterotoxigen
escherichia
coli
etec
classifi
heat
labil
lt
heat
stabl
st
induc
diarrhea
host
mechan
villou
hypersecret
lt
consist
singl
domain
five
b
subunit
b
subunit
lt
b
bind
predominantli
gangliosid
act
receptor
eukaryot
cell
surfac
fusion
protein
consist
green
fluoresc
protein
gfp
st
lt
b
gfpstlt
b
express
extracellularli
lactobacillu
reuteri
oral
inocul
recombin
lactobacilli
mice
elicit
signific
induct
serum
igg
mucos
iga
stlt
b
mice
vaccin
recombin
l
reuteri
intragastr
challeng
etec
fulli
protect
fluid
influx
respons
gut
contrast
mice
control
group
display
massiv
fluid
accumul
challeng
fy
fimbrial
adhesin
import
etec
infect
neonat
anim
less
preval
usual
accompani
fimbrial
antigen
one
major
adher
factor
found
etec
neonat
calv
pig
immun
mice
intranas
oral
recombin
l
casei
cell
express
fimbrial
antigen
cell
surfac
result
high
level
serum
igg
mucos
iga
etec
mice
immun
recombin
lactobacilli
protect
etec
follow
oral
challeng
standardtyp
etec
regardless
immun
rout
howev
mortal
observ
control
mice
challeng
moreov
l
acidophilu
express
fimbrial
adhesin
secret
cellassoci
form
show
inhibit
competit
etec
adhes
intestin
brush
border
pig
dosedepend
manner
oral
inocul
mice
l
casei
express
fimbrial
adhesin
cell
surfac
elicit
mucos
iga
site
inocul
well
remot
mucos
site
high
level
system
specif
igg
also
induc
mice
vaccin
recombin
l
casei
protect
oral
challeng
standardtyp
etec
control
mice
die
challeng
etec
strain
produc
fimbria
surfac
commonli
induc
diarrhea
piglet
faeg
structur
subunit
fimbria
shown
oral
administr
recombin
l
lacti
cell
express
fimbrial
adhesin
secret
cellassoci
form
icr
mice
could
success
induc
secret
igg
antibodi
follow
intragastr
challeng
standardtyp
etec
mortal
rate
mice
vaccin
recombin
lactococci
control
group
mice
fimbrial
e
coli
strain
associ
porcin
postwean
diarrhea
pig
edema
diseas
adher
fimbrial
e
coli
porcin
intestin
epitheli
cell
mediat
fedf
adhesin
fimbria
develop
mucos
vaccin
porcin
postwean
diarrhea
edema
diseas
differ
express
cassett
display
fedf
cell
surfac
l
lacti
construct
preliminari
attempt
express
entir
fedf
protein
fusion
protein
l
lacti
result
ineffici
secret
degrad
adhesin
therefor
region
fedf
requir
bind
specif
porcin
intestin
epitheli
cell
use
construct
cell
surfac
display
system
initi
recombin
l
lacti
clone
secret
partial
overlap
receptor
bind
domain
fedf
amino
acid
residu
fusion
h
domain
l
lacti
proteinas
p
prtp
protein
prepar
use
two
differ
signal
peptid
substanti
higher
level
fusion
protein
fourto
sixfold
secret
clone
possess
lactobacillu
brevi
slpa
signal
peptid
possess
l
lacti
signal
peptid
construct
surfac
display
system
secret
protein
anchor
cell
wall
l
lacti
via
cell
wall
anchor
region
lactococc
acetyl
muramidas
acma
protein
lactococc
prtp
protein
three
group
express
vector
prtp
spacer
sequenc
kb
also
design
wholecel
elisa
detect
cell
surfac
exposur
fedf
receptor
bind
region
show
acma
anchor
perform
significantli
better
prtp
anchor
particularli
l
lacti
mutant
devoid
extracellular
housekeep
proteas
htra
among
cell
surfac
display
system
possess
acma
anchor
longest
prtp
spacer
result
effici
bind
recombin
l
lacti
cell
porcin
intestin
epitheli
cell
report
flagellin
salmonella
signific
vaccin
potenti
surfac
antigen
salmonella
detect
mitogen
stimulatori
effect
lymphocyt
bacteri
flagellin
also
induc
innat
immun
respons
interact
tolllik
receptor
recombin
l
casei
cell
express
flagellin
salmonella
enterica
serovar
enteritidi
cell
surfac
lcf
construct
enteritidi
count
spleen
mice
immun
recombin
l
casei
cfu
less
control
mice
intragastr
challeng
enteritidi
signific
differ
level
protect
immun
recombin
lactobacilli
compar
free
flagellin
isol
enteritidi
although
amount
flagellin
carri
lcf
less
free
flagellin
immun
mice
recombin
lactobacilli
result
antigenspecif
antibodi
respons
either
fece
sera
induc
releas
interferon
ifn
c
restimul
prime
lymphocyt
ex
vivo
result
suggest
protect
efficaci
provid
flagellinexpress
l
casei
mainli
attribut
cellmedi
immun
respons
level
ifnc
produc
prime
flagellinrestimul
lymphocyt
compar
recombin
l
casei
cell
express
flagellin
cell
surfac
mixtur
purifi
flagellin
normal
l
casei
result
indic
lactobacillu
strain
function
adjuv
flagellin
express
cell
surfac
listeriolysin
llo
major
virul
factor
listeria
monocytogen
upon
phagocytosi
secret
llo
form
pore
phagosom
membran
enabl
access
bacterium
cytoplasm
host
cell
addit
role
llo
intracellular
pathogenesi
l
monocytogen
also
major
immunodomin
listeri
antigen
antilisteri
protect
immun
depend
cytotox
cellmedi
immun
llo
evalu
potenti
l
lacti
vaccin
platform
listeriosi
llo
express
bacterium
use
either
constitut
promot
induc
promot
pnisa
intracellular
secret
form
llo
express
constitut
intracellular
cassett
howev
construct
capabl
effici
express
llo
activ
form
hemolyt
activ
contrast
l
monocytogen
cell
recombin
lactococc
strain
unabl
grow
macrophagelik
cell
recombin
strain
test
murin
model
evalu
vaccin
efficaci
l
monocytogen
infect
tlymphocyt
specif
llo
epitop
detect
strain
administ
via
intraperiton
oral
rout
l
lacti
cell
express
llo
intracellularli
induc
promot
abl
elicit
serum
antibodi
respons
howev
two
lactococc
strain
secret
llo
abl
induc
signific
serum
antibodi
respons
administ
intraperiton
rout
oral
rout
follow
intraperiton
challeng
l
monocytogen
greatest
protect
listeri
organ
colon
attain
mice
immun
induc
llosecret
l
lacti
cell
via
intraperiton
rout
correl
highest
llo
express
level
bacteri
strain
listeri
count
liver
spleen
mice
immun
l
lacti
cfuorgan
respect
mice
immun
induc
llosecret
l
lacti
cfuorgan
cellular
locat
antigen
influenc
strength
elicit
immunolog
respons
export
antigen
secret
medium
cell
surfac
anchor
better
recogn
immun
system
produc
intracellularli
furthermor
intracellular
product
antigen
may
limit
vivo
releas
hallingbrown
et
al
show
sever
vaccin
antigen
experiment
known
confer
immun
protect
bacteri
pathogen
least
one
anim
model
human
diseas
either
secret
bacterium
locat
cell
surfac
confirm
valid
assumpt
immunogen
protein
quickli
readili
visibl
host
immun
system
howev
compar
intracellular
antigen
export
antigen
suscept
proteolyt
degrad
expos
host
bodi
fluid
promis
candid
vaccin
yersinia
low
calcium
respons
v
lcrv
antigen
lcrv
circumv
host
innat
immun
induc
product
antiinflammatori
cytokin
interleukin
il
particip
secret
transloc
yersinia
outer
protein
toxin
phagocyt
follow
intranas
deliveri
recombin
l
lacti
cell
secret
yersinia
pseudotuberculosi
lcrv
lllcrv
antigen
induc
specif
system
mucos
antibodi
respons
cellular
immun
vaccin
mice
nineti
percent
anim
vaccin
lllcrv
protect
oral
pseudotuberculosi
challeng
wherea
control
mice
surviv
challeng
furthermor
mice
immun
lllcrv
surviv
complet
follow
intraven
challeng
pseudotuberculosi
kill
control
mice
howev
specif
system
mucos
immun
respons
trigger
oral
immun
mice
recombin
l
lacti
rout
confer
protect
oral
pseudotuberculosi
challeng
intranas
vaccin
mice
recombin
lactococci
show
protect
intraderm
yersinia
pesti
challeng
applic
lcrv
antigen
confer
cross
protect
close
relat
yersinia
speci
bacillu
anthraci
produc
two
exotoxin
share
common
cell
receptor
bind
protein
protect
antigen
pa
origin
identifi
protein
provid
protect
infect
experiment
anim
vaccin
strategi
establish
util
lactobacillu
acidophilu
deliv
pa
dendrit
cell
dc
via
use
specif
dctarget
peptid
oral
vaccin
aj
mice
l
acidophilu
express
fusion
pa
nterminu
dctarget
peptid
secret
form
activ
mucos
antigenpres
cell
turn
induc
antipa
neutral
antibodi
iga
secret
tcell
immun
b
anthraci
seventyf
percent
immun
mice
protect
intraperiton
challeng
b
anthraci
strain
stern
contrast
l
acidophilu
express
pa
fuse
control
peptid
improv
dc
bind
show
lower
level
protect
current
anthrax
vaccin
rpa
adsorb
alhydrogel
given
singl
subcutan
inject
protect
immun
mice
lethal
challeng
b
anthraci
strain
stern
result
highlight
efficaci
employ
lab
vaccin
platform
wherebi
microbi
immunogen
deliv
mucos
dc
use
small
dctarget
peptid
may
enhanc
antigen
uptak
dc
sever
potenti
virul
factor
suggest
uropathogen
proteu
mirabili
includ
mannoseresist
proteuslik
fimbria
mrp
mrp
fimbria
may
contribut
colon
urinari
tract
p
mirabili
structur
protein
mrp
mrpa
repres
promis
candid
antigen
mucos
vaccin
mrpa
effici
express
l
lacti
cell
wallanchor
secret
form
mice
use
immunolog
protect
studi
signific
induct
serum
igg
respons
observ
mice
intranas
immun
recombin
lactococci
secret
mrpa
signific
induct
serum
iga
respons
observ
mice
intranas
immun
recombin
lactococci
express
mrpa
cell
wallanchor
form
howev
induct
mucos
antibodi
respons
observ
strain
addit
l
lacti
secret
mrpa
abl
induc
signific
ifnc
product
protect
assay
show
p
mirabili
kidney
colon
mice
immun
recombin
l
lacti
cell
less
mice
treat
phosphat
buffer
salin
pb
although
studi
indic
influenc
antigen
cellular
locat
type
induc
immunolog
respons
extens
studi
requir
elucid
correl
antigen
cellular
local
type
immunolog
respons
pertussi
toxin
pt
ab
toxin
consist
aprotom
subunit
toxic
subunit
boligom
pentam
bind
surfac
receptor
eukaryot
cell
transloc
toxic
subunit
across
cell
membran
subunit
consid
major
immunogen
elicit
neutral
antibodi
pt
streptococcu
gordonii
cell
express
ntermin
amino
acid
subunit
pt
bordetella
pertussi
cell
surfac
capabl
elicit
serum
immun
respons
new
zealand
white
rabbit
inject
subcutan
howev
induc
antibodi
show
weak
abil
neutral
cytotox
effect
pt
chines
hamster
ovari
cho
cell
mice
immun
intraperiton
recombin
heatkil
gordonii
fulli
protect
toxic
effect
pt
inject
intraperiton
leukocytosispromot
histamin
sensit
assay
wherea
nonimmun
mice
surviv
challeng
shown
high
titer
antibodi
outer
surfac
protein
ospa
tickborn
spirochet
borrelia
burgdorferi
prevent
borrelia
infect
mice
mutant
ospa
construct
autoantigen
sequenc
ospa
replac
analog
region
nonarthritogen
european
speci
borrelia
afzelii
possess
compensatori
chang
ctermin
mutant
ospa
stabil
replac
analog
region
b
afzelii
signific
mucos
iga
serum
igg
respons
induc
mice
vaccin
oral
l
plantarum
express
either
wild
type
lpa
mutant
ospa
lpaa
protect
vaccin
mice
infect
determin
absenc
b
burgdorferi
dissemin
challeng
ixod
scapulari
nymph
carri
b
burgdorferi
mice
immun
either
lpa
lpaa
free
spirochet
wherea
control
mice
infect
b
burgdorferi
surfac
protect
antigen
spaa
erysipelothrix
rhusiopathia
secret
matur
form
bind
bacteri
cell
surfac
via
ctermin
region
compris
tandem
gw
repeat
ntermin
region
spaa
respons
elicit
protect
immun
e
rhusiopathia
oral
nasal
vaccin
ddi
mice
recombin
lactococci
produc
spaa
secret
form
elicit
antigenspecif
serum
igg
fecal
iga
respons
immun
mice
fulli
protect
challeng
e
rhusiopathia
inner
thigh
contrast
none
mice
control
group
surviv
challeng
develop
safe
effect
inexpens
vaccin
capabl
induc
mucos
system
immun
highli
desir
prevent
spread
human
immunodefici
viru
hiv
hiv
type
envelop
protein
mediat
sequenti
bind
coreceptor
interact
trigger
conform
chang
envelop
protein
result
fusion
viral
cellular
membran
recombin
l
lacti
vector
express
loop
envelop
protein
cell
surfac
construct
loop
immunogen
epitop
envelop
protein
oral
immun
mice
use
cholera
toxin
adjuv
induc
high
level
hivspecif
serum
igg
fecal
iga
antibodi
furthermor
vaccin
induc
strong
hivspecif
cellmedi
immun
number
ifncsecret
cell
significantli
greater
mice
vaccin
control
mice
absolut
number
hivspecif
ifncsecret
lymphocyt
higher
intestin
lymph
node
spleen
mice
suggest
oral
immun
particularli
effect
induc
mucos
immun
cell
abl
infect
immatur
dc
induc
hivspecif
cytotox
tlymphocyt
respons
intraperiton
challeng
vaccinia
viru
express
envelop
protein
viral
load
mice
lower
control
mice
spike
protein
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
type
envelop
glycoprotein
respons
receptor
bind
viru
fusion
also
consid
major
target
vaccin
develop
sar
abil
elicit
viru
neutral
antibodi
two
segment
sarscov
protein
includ
bcell
epitop
receptor
bind
domain
locat
nterminu
express
surfac
l
casei
cell
mice
immun
either
oral
intranas
recombin
l
casei
oral
rout
recombin
l
casei
cell
suspens
administ
daili
via
intragastr
lavag
day
lighter
schedul
employ
nasal
immun
recombin
l
casei
cell
suspens
inocul
daili
nostril
lightli
anesthet
mice
day
oral
intranas
inocul
mice
recombin
l
casei
cell
result
high
level
serum
igg
mucos
iga
respons
detect
intestin
bronchoalveolar
lavag
fluid
induc
antibodi
mount
potent
neutral
activ
sarspseudoviru
antivir
activ
serum
igg
oral
immun
mice
intranas
immun
mice
antivir
activ
observ
serum
igg
mice
control
group
neutral
activ
antisar
iga
intestin
lavag
fluid
mice
immun
oral
contrast
low
level
neutral
activ
observ
bronchoalveolar
lavag
fluid
intranas
immun
mice
antivir
activ
antisar
iga
bronchoalveolar
lavag
fluid
moder
level
howev
littl
detect
intestin
lavag
fluid
control
group
antivir
activ
detect
bronchoalveolar
lavag
fluid
low
level
neutral
activ
observ
intestin
lavag
fluid
case
human
papillomaviru
hpv
relat
cervic
cancer
associ
hpv
type
major
capsid
protein
spontan
self
assembl
viruslik
particl
vlp
structur
morpholog
similar
nativ
papillomaviru
express
cytoplasm
l
casei
l
abl
selfassembl
vlp
intracellularli
howev
l
cell
exhibit
differ
vlp
product
pattern
cell
exhibit
larg
amount
vlp
electrondens
bodi
contain
vlp
aggreg
cell
exhibit
reduc
product
vlp
moreov
size
l
caseiproduc
vlp
heterogen
rang
nm
diamet
size
rang
vlp
use
commerci
vaccin
interestingli
l
casei
cell
lm
length
wherea
normal
l
casei
cell
rang
lm
length
furthermor
growth
rate
l
cell
lower
wild
type
strain
vlp
express
l
casei
recogn
vlp
conform
antibodi
suggest
protein
produc
l
casei
selfassembl
vlplike
structur
display
vlpspecif
conform
epitop
epitop
import
elicit
viru
neutral
antibodi
igg
detect
sera
mice
immun
subcutan
l
sera
recogn
assembl
vlp
disassembl
vlp
indic
express
l
casei
exist
within
vlp
well
unfold
protein
howev
nasal
inocul
mice
l
produc
mucos
system
humor
respons
attribut
insuffici
level
protein
present
recombin
lactobacilli
mucos
site
vaccin
base
virion
capsid
protein
unlik
applic
therapeut
infect
patient
sinc
capsid
protein
absent
cervic
cancer
cxca
cell
contrast
oncoprotein
constitut
express
cxca
cell
malign
progress
cervic
lesion
may
therefor
effect
target
cancer
immunotherapi
antigen
express
surfac
l
casei
cell
employ
polycglutam
acid
synthetas
complex
pgsa
cell
surfac
anchor
motif
l
oral
immun
mice
l
induc
system
mucos
intestinalvagin
iga
humor
immun
respons
significantli
enhanc
boost
addit
system
local
cellmedi
immun
respons
elicit
mous
vagina
mous
tumor
model
anim
receiv
l
oral
gener
antitumor
effect
express
murin
tumor
averag
tumor
size
vaccin
anim
smaller
control
mice
addit
surviv
rate
mice
immun
recombin
lactobacilli
wherea
control
mice
die
howev
antitumor
effect
l
high
mayb
caus
low
immunogen
mucos
immun
low
level
antigen
display
l
casei
cell
cell
l
lacti
also
engin
express
cell
surfac
coadministr
anoth
lactococci
secret
investig
immun
immunotherapi
hpvrelat
cxca
heterodimer
cytokin
induc
respons
enhanc
cytotox
tlymphocyt
ctl
matur
promot
natur
killer
nk
cell
activ
induc
ifnc
product
mice
vaccin
intranas
challeng
inject
tissu
cultur
number
tumor
cell
mice
vaccin
l
lacti
alon
die
follow
develop
aggress
tumor
contrast
mice
vaccin
remain
tumor
free
tumor
median
size
remain
tumorbear
mice
lower
measur
immun
mice
coadministr
result
significantli
higher
antitumor
activ
inocul
mice
remain
tumor
free
tumor
median
size
remain
tumorbear
anim
immun
mice
antitumor
activ
elicit
covaccin
appear
longlast
tumor
free
anim
rechalleng
month
later
cell
remain
tumor
free
month
cellmedi
respons
elicit
mucos
covaccin
depend
like
respons
tumor
protect
howev
experi
perform
mice
sacrif
day
last
inject
longterm
protect
mice
investig
therapeut
effect
coadministr
mice
first
challeng
tumor
cell
line
initi
immunotherapi
mice
palpabl
tumor
immunotherapi
start
treatment
result
total
tumor
regress
immun
anim
moreov
tumor
median
size
remain
tumorbear
mice
lower
measur
mice
treat
respect
contrast
tumor
regress
observ
mice
treat
alon
mice
immun
also
exhibit
system
mucos
humor
respons
induc
higher
level
mice
vaccin
flavivir
e
protein
major
envelop
protein
dengu
viru
protein
mostli
glycosyl
essenti
viral
infect
via
receptormedi
endocytosi
domain
iii
e
protein
ediii
function
cellular
receptor
bind
domain
dengu
viru
human
mosquito
cell
ediii
domain
dengu
viru
serotyp
express
cytoplasm
cell
l
lacti
strain
llediii
antigen
produc
solubl
nondegrad
form
late
exponenti
phase
point
bacteria
use
immun
mice
dengu
viru
bloodborn
pathogen
system
antibodi
respons
determin
balbc
mice
nasal
oral
administr
llediii
result
induct
antiediii
antibodi
sera
vaccin
mice
howev
antibodi
respons
depend
mous
strain
rout
administr
addit
heterogen
observ
level
antibodi
respons
anim
within
group
immun
llediii
protect
immun
respons
elicit
immun
anim
protect
potenti
immun
sera
measur
use
plaqu
reduct
neutral
test
pool
sera
balbc
mice
vaccin
heat
inactiv
viru
abl
inhibit
viral
replic
respect
pool
sera
control
anim
exhibit
neutral
activ
viru
immun
sera
mice
inocul
oral
llediii
show
higher
neutral
activ
compar
nasallyimmun
anim
antivir
activ
sera
balbc
mice
inocul
nasal
llediii
respect
howev
virus
neutral
activ
sera
balbc
mice
inocul
oral
llediii
respect
addit
result
indic
level
antiediii
igg
antibodi
directli
correl
plaqu
neutral
activ
rotaviru
particl
possess
outer
capsid
compos
cell
attach
protein
viral
hemagglutinin
compon
abl
elicit
viru
neutral
antibodi
express
l
lacti
secret
cell
wallanchor
form
intragastr
immun
mice
lactococc
strain
express
result
induct
antigenspecif
antibodi
respons
anim
anchor
cell
wall
l
lacti
result
reduc
abil
induc
antibodi
antibodi
show
neutral
activ
rotaviru
infect
monkey
kidney
cell
contrast
recombin
lactococci
secret
immunogen
sera
immun
mice
abl
neutral
viru
infect
wherea
sera
mice
inocul
parent
lactococci
oral
immun
mice
l
lacti
cell
express
cell
surfac
result
induct
serum
igg
mucos
iga
induc
antibodi
inhibit
cytopath
porcin
rotaviru
infect
cell
dosedepend
manner
contrast
sera
control
mice
could
inhibit
virusinduc
cytopathoc
splenic
cell
mice
immun
l
lacti
cell
significantli
increas
follow
specif
stimul
purifi
porcin
rotaviru
protein
compar
prolifer
spleen
cell
harvest
control
mice
oral
immun
mice
l
casei
cell
express
fusion
lt
b
b
cell
surfac
also
trigger
induct
serum
igg
mucos
iga
respons
igg
level
sera
mice
immun
recombin
l
casei
cell
similar
reduct
viru
cytopath
effect
observ
use
serum
igg
mice
fed
l
casei
express
l
casei
express
b
relat
control
mice
respect
addit
l
casei
cell
express
b
induc
higher
level
mucos
iga
respons
vaccin
anim
l
casei
cell
express
alon
result
demonstr
specif
mucos
adjuvant
lt
b
spike
protein
transmiss
gastroenter
viru
tgev
one
main
structur
protein
viru
involv
attach
host
cell
induct
fusion
viral
cellular
membran
initi
stage
infect
protein
use
mainli
induct
protect
immun
tgev
relev
neutral
epitop
map
ntermin
domain
protein
recombin
l
lacti
cell
express
ntermin
globular
domain
protein
cell
surfac
construct
oral
immun
mice
recombin
lactococci
result
product
intestin
mucos
iga
serum
igg
respons
induc
antibodi
demonstr
neutral
effect
tgev
infect
plaqu
reduct
assay
reduct
viru
plaqu
number
obtain
use
sera
intestin
lavag
mice
immun
recombin
l
lacti
relat
control
mice
respect
l
casei
strain
shirota
express
protein
tgev
secret
form
also
examin
mucos
vaccin
tgev
oral
immun
mice
recombin
lactobacilli
constitut
express
protein
induc
mucos
system
immun
respons
tgev
induc
antibodi
exhibit
neutral
effect
viru
infect
plaqu
reduct
assay
reduct
number
viru
plaqu
obtain
use
intestin
lavag
sera
mice
fed
recombin
l
casei
compar
control
mice
nucleocapsid
protein
import
induc
immun
respons
porcin
epidem
diarrheal
viru
pedv
oral
intranas
inocul
pregnant
sow
mice
l
casei
cell
express
nucleocapsid
protein
pedv
cell
surfac
elicit
serum
igg
mucos
iga
respons
background
level
immunolog
respons
detect
control
anim
follow
oral
vaccin
level
iga
colostrum
pregnant
sow
greater
igg
suckl
colostrum
secret
sow
previous
inocul
recombin
l
casei
cell
igg
level
piglet
increas
slightli
howev
igg
purifi
sera
immun
pregnant
sow
piglet
suckl
colostrum
inhibit
plaqu
format
pedv
similarli
colostrum
iga
inhibit
plaqu
format
one
structur
polypeptid
porcin
parvoviru
ppv
icosahedron
protein
coat
encompass
major
antigen
domain
ppv
may
induc
neutral
antibodi
inhibit
ppv
infect
recombin
strain
l
casei
construct
produc
two
cellular
locat
either
extern
milieu
anchor
cell
surfac
follow
oral
administr
recombin
strain
abl
elicit
ppvspecif
system
mucos
antibodi
respons
mice
howev
highest
antibodi
titer
obtain
l
casei
produc
protein
extracellular
milieu
induc
antibodi
demonstr
neutral
activ
ppv
infect
plaqu
reduct
assay
intestin
lavag
sera
parent
l
casei
use
neg
control
determin
plaqu
reduct
percentag
reduct
number
plaqu
observ
use
intestin
lavag
sera
mice
vaccin
l
casei
express
extern
milieu
plaqu
reduct
percentag
use
intestin
lavag
sera
mice
vaccin
l
casei
display
cell
surfac
respect
merozoit
surfac
protein
present
speci
plasmodium
wide
studi
major
vaccin
candid
malaria
carboxi
termin
fragment
shown
immuneeffect
challeng
plasmodium
parasit
plasmodium
yoelii
express
intracellularli
l
lacti
oral
administr
recombin
lactococci
balbc
mice
result
reduc
parasitemia
compar
control
mice
inocul
l
lacti
cell
challeng
asexu
blood
stage
p
yoelli
parasit
howev
case
mice
member
control
group
mice
immun
normal
l
lacti
cell
die
infect
p
yoelii
wherea
mice
vaccin
recombin
l
lacti
surviv
parasit
erad
major
compon
cyst
wall
structur
giardia
lamblia
newli
express
molecular
mass
kda
possess
hydrophob
ntermin
signal
peptid
kda
carboxi
end
tail
region
howev
matur
detect
within
cyst
wall
migrat
kda
sinc
lack
kda
tail
portion
post
translat
process
addit
matur
form
contain
relev
bcell
epitop
oral
immun
mice
recombin
lactococci
express
matur
cell
surfac
result
induct
mucos
iga
antibodi
intestin
challeng
experi
giardia
muri
mice
immun
recombin
lactococc
cell
show
less
cyst
output
nonimmun
control
mice
lab
appear
attract
vehicl
vaccin
deliveri
abl
induc
mucos
system
immun
respons
howev
import
increas
potenc
system
obtain
high
level
protect
immun
respons
lower
dose
abil
lab
carrier
induc
protect
infect
agent
depend
suffici
antigen
deliveri
vivo
optim
lab
carrier
requir
select
suitabl
lab
strain
mode
antigen
present
cytoplasm
secret
cell
surfac
expos
immun
regimen
rout
dose
time
coadministr
immunoregulatori
cytokin
lab
vehicl
addit
coexpress
antigen
adjuv
antigenpres
cell
target
peptid
lab
vehicl
repres
valuabl
step
toward
increas
effici
vaccin
develop
involv
improv
genet
tool
although
sequenc
current
avail
secret
anchor
protein
peptid
lab
process
often
ineffici
result
reduc
level
secret
surfaceexpos
antigen
character
secret
anchor
regulatori
signal
genom
sequenc
improv
featur
furthermor
low
transform
effici
lab
major
obstacl
prepar
lab
vaccin
establish
effici
transform
protocol
therefor
necessari
method
also
devis
analyz
vivo
antigen
product
level
fate
administ
lab
vaccin
ongo
studi
probiot
effect
lab
interact
immun
system
may
ultim
help
identifi
strain
lab
appropri
benefici
particular
vaccin
deliveri
system
dna
vaccin
advanc
vaccin
methodolog
involv
direct
inocul
plasmid
vector
deriv
bacteria
contain
gene
encod
antigen
interest
control
eukaryot
promot
host
taken
cell
antigen
express
process
transport
cell
surfac
recognit
immun
cell
moreov
baculovirus
group
insect
virus
use
effici
express
vector
product
recombin
vaccin
insect
mammalian
cell
virus
possess
rodshap
capsid
condens
dna
genom
consist
doublestrand
coval
close
circular
molecul
rang
kbp
length
packag
lab
vaccin
produc
bacteri
ferment
manufactur
cost
lower
either
dna
vaccin
plasmid
vector
purifi
bacteri
host
vaccin
deriv
mammalian
insect
cell
cultur
infect
baculovirus
administr
dna
vaccin
mostli
carri
invas
method
includ
intramuscular
inject
intraderm
gene
gun
deliveri
cumbersom
mass
vaccin
immun
could
also
induc
upon
mucos
administr
howev
elicit
immunolog
respons
use
oral
rout
requir
encapsul
dna
vaccin
biodegrad
polymer
microspher
impos
addit
cost
approach
protect
dna
enzymat
degrad
acid
hydrolysi
pass
upper
gastrointestin
tract
contrast
describ
review
sever
lab
vaccin
elicit
adequ
protect
level
infecti
agent
without
encapsul
eukaryot
cell
uptak
dna
vaccin
immun
host
use
baculoviru
base
product
system
abl
perform
rang
post
translat
modif
instanc
glycosyl
common
lab
result
viral
infect
use
dna
vaccin
baculoviru
system
deriv
vaccin
favor
lab
vaccin
viral
antigen
post
translat
modif
glycosyl
carri
obtain
adequ
immunolog
respons
contrast
lab
system
prefer
vaccin
construct
use
antigen
nativ
nonglycosyl
bacteri
antigen
addit
baculoviru
infect
ultim
result
cell
death
lysi
heterolog
gene
express
continu
everi
round
synthesi
vaccin
interest
requir
infect
new
cell
therefor
system
inferior
lab
system
term
capac
continu
product
recombin
vaccin
date
data
obtain
regard
lab
vaccin
promis
indic
lab
capabl
deliv
antigen
mucos
system
immun
system
elicit
protect
infect
agent
howev
clinic
trial
yet
report
lab
vaccin
releas
genet
modifi
organ
clinic
use
rais
legitim
safeti
concern
surviv
propag
environ
transfer
genet
materi
antibiot
select
marker
antigen
encod
gene
microorgan
therefor
proper
biolog
contain
strategi
implement
clinic
applic
lab
vaccin
prevent
escap
environ
genet
modifi
microorgan
genet
materi
exist
foodgrad
express
system
lab
reli
foodgrad
marker
select
recombin
bacteria
instead
antibiot
resist
marker
expand
inhibit
transfer
antibiot
resist
gene
microorgan
lab
mayb
consid
promis
vehicl
antigen
also
biolog
activ
compound
immunomodul
antibodi
enzym
peptid
genet
modifi
lactococcu
lacti
secret
provid
therapeut
approach
inflammatori
bowl
diseas
address
safeti
concern
relat
releas
genet
modifi
organ
clinic
use
chromosom
thymidyl
synthas
thya
gene
replac
gene
gener
thymin
auxotroph
viabil
thya
strain
reduc
sever
order
magnitud
absenc
thymidin
thymin
case
follow
shed
bacterium
environ
contain
valid
vivo
pig
notabl
small
phase
human
clinic
trial
conduct
thya
strain
patient
crohn
diseas
show
contain
strategi
effect
also
mucos
deliveri
l
lacti
feasibl
human
actogenix
compani
perform
clinic
phase
iia
studi
secret
l
lacti
human
subject
moder
activ
ulcer
coliti
result
studi
confirm
suitabl
appli
contain
system
human
first
clinic
trial
pave
way
develop
labdeliveri
applic
human
includ
vaccin
deliveri
futur
